Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Bolt Biotherapeutics, Inc. (BOLT) had Free Cash Flow per Share of $-1.60 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$7.69M |
|
$-63.12M |
|
-- |
|
$7.69M |
|
$80.74M |
|
$-73.05M |
|
$9.93M |
|
$-63.12M |
|
$-63.12M |
|
$-63.12M |
|
$-63.12M |
|
$-63.12M |
|
$-63.12M |
|
$-73.05M |
|
$-73.88M |
|
38.18M |
|
38.18M |
|
$-1.65 |
|
$-1.65 |
|
| Balance Sheet Financials | |
$50.81M |
|
$3.14M |
|
$48.82M |
|
$99.63M |
|
$15.86M |
|
$22.96M |
|
$26.58M |
|
$42.43M |
|
$57.20M |
|
$57.20M |
|
$57.20M |
|
38.34M |
|
| Cash Flow Statement Financials | |
$-61.29M |
|
$57.58M |
|
$0.11M |
|
$12.57M |
|
$8.97M |
|
$-3.60M |
|
$7.41M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.20 |
|
-- |
|
-- |
|
0.29 |
|
0.40 |
|
100.00% |
|
-949.91% |
|
-949.91% |
|
-960.75% |
|
-820.78% |
|
-820.78% |
|
$-61.18M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
-- |
|
-- |
|
-- |
|
-110.35% |
|
-110.35% |
|
-63.35% |
|
-78.74% |
|
$1.49 |
|
|
Free Cash Flow per Share |
$-1.60 |
$-1.61 |
|